Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Evithrom Market Growth Potential: How Will Market Size Shift Through 2030?
Historical expansion can be attributed to the elevated risks of blood loss during surgical operations, the demand for hemostasis that acts rapidly, the initial application of thrombin products, a rise in trauma incidents, and their subsequent integration into orthopedic procedures.
Anticipated growth during the forecast period stems from an increase in surgical procedures, a surge in accident and trauma incidents, the expansion of hospital facilities, advancements in thrombin product development, and a heightened emphasis on ensuring surgical safety.
Key trends observed for the forecast period involve an increasing adoption of topical hemostatic agents, escalating demand within cardiovascular surgical contexts, the enlargement of trauma and emergency medical services, a preference for solutions that facilitate quick clot formation, and the greater uptake of human thrombin-based products.
Get A Free Sample Report With In-Depth Market Insights:
Evithrom Market Growth Factors: What’s Supporting Expansion?
The evithrom market is anticipated to grow as the number of surgical interventions increases. Surgical procedures encompass medical operations or treatments involving the physical manipulation or alteration of tissues and organs within the body. The expansion in surgical procedures is primarily fueled by advancements in medical technology, which enhance the safety and efficiency of operations, and by the rising prevalence of chronic conditions necessitating more surgical interventions. Evithrom is utilized in surgical settings to control bleeding by promoting clot formation and improving hemostasis, especially in high-risk procedures such as cardiovascular or orthopedic surgeries. For instance, in June 2024, as per the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based non-profit organization, liposuction remained the most prevalent surgical procedure in 2023, with over 2.2 million performed, while face and head procedures showed considerable growth, escalating by 19.6% to more than 6.5 million. Hence, the increasing volume of surgical procedures is a key driver for the evithrom market’s expansion.
Evithrom Market Segment Landscape: Which Areas Lead Development?
The evithrom market covered in this report is segmented –
1) By Indication: Surgical Hemostasis, Trauma Care
2) By Formulation: Bovine Thrombin, Human Thrombin, Recombinant Thrombin
3) By Distribution Channel: Hospitals, Clinics And Diagnostic Centers, Online Pharmacies
Evithrom Market Industry Leaders And Competitive Landscape
Major companies operating in the evithrom market are Johnson & Johnson Inc.
View The Full Evithrom Market Report:
Evithrom Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the evithrom market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the evithrom market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
